JRANX
Price
$80.71
Change
-$0.23 (-0.28%)
Updated
May 9 closing price
Net Assets
22.41B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

JRANX vs RGAHX

Header iconJRANX vs RGAHX Comparison
Open Charts JRANX vs RGAHXBanner chart's image
Janus Henderson Research N
Price$80.71
Change-$0.23 (-0.28%)
VolumeN/A
Net Assets22.41B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
JRANX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JRANX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JRANX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. JRANX (22.4B). RGAHX pays higher dividends than JRANX: RGAHX (0.54) vs JRANX (0.00). JRANX was incepted earlier than RGAHX: JRANX (13 years) vs RGAHX (9 years). JRANX (0.55) is less costly to investors than RGAHX (0.44). JRANX is a more actively managed with annual turnover of: 27.00 vs. RGAHX (25.00). RGAHX has a lower initial minimum investment than JRANX: RGAHX (250) vs JRANX (1000000). JRANX annual gain was more profitable for investors over the last year : 6.48 vs. RGAHX (3.25). JRANX return over 5 years is better than : 65.10 vs. RGAHX (44.87).
JRANXRGAHXJRANX / RGAHX
Total Expense Ratio0.550.44125%
Annual Report Gross Expense Ratio0.550.44125%
Fund Existence13 years9 years-
Gain YTD-4.823-2.478195%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets22.4B285B8%
Annual Yield % from dividends0.000.54-
Returns for 1 year6.483.25199%
Returns for 3 years61.8233.40185%
Returns for 5 years65.1044.87145%
Returns for 10 years82.71N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics